Merging the portfolios and strengths of Philips and Spectranetics

642

At the recent Vascular Interventional Advances 2017 conference (VIVA; 11–14 September, Las Vegas, USA), Vascular News caught up with Philips’ Atul Gupta (Global Chief Medical Officer, Image Guided Therapy) and Will Martin (Peripheral Segment Leader, Image Guided Therapy) to hear about the significance of the company’s recent acquisition of Spectranetics.

LEAVE A REPLY